Nusa Raya Cipta Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Nusa Raya Cipta Tbk. trades at Rp520 (market cap 1.34T, 802.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 7.8K 24h volume). The key difference: Nusa Raya Cipta Tbk. is far larger — about 7.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Nusa Raya Cipta Tbk. is more actively traded (802.9K versus 7.8K). Which is the better fit depends on your goals.
| NRCA | OBAT | |
|---|---|---|
Market Cap | 1.34T | 172.82B |
Volume | 802.9K | 7.8K |
Lot | 8.03K | 78 |
Turnover | 421.44M | 1.96M |
Average Price | 524.89 | 251.82 |
Value | 421.44M | 1.96M |
Indicative Equilibrium Price | 535 | 254 |
Indicative Equilibrium Volume | 48.3K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusa Raya Cipta Tbk (the Company) was establised based on notarial deed No. 134 of Ny Kartini Muljadi, SH., dated September 17, 1975.
Read more on NRCA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →